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Abstract
In recent years, the increasing availability of individual-level data and the advancement
of machine learning algorithms have led to the explosion of methodological development for
finding optimal individualized treatment rules (ITRs). These new tools are being applied
in a variety of fields including business, medicine, and politics. However, there exist few
methods that empirically evaluate the efficacy of ITRs. In particular, many of the existing
ITR estimators are based on complex models and do not come with statistical uncertainty
estimates. We consider common real-world settings, in which policy makers wish to predict
the performance of a given ITR prior to its administration in a target population. We
propose to use a randomized experiment for evaluating ITRs. Unlike the existing methods,
the proposed methodology is based on Neyman’s repeated sampling approach and does not
require modeling assumptions. As a result, it is applicable to the empirical evaluation of
ITRs derived from a wide range of statistical and machine learning models. We conduct a
simulation study to demonstrate the accuracy of the proposed methodology in small samples.
We also apply our methods to the Project STAR (Student-Teacher Achievement Ratio)
experiment to compare the performance of ITRs that are based on popular machine learning
methods used for estimating heterogeneous treatment effects.
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1 Introduction
In recent years, the increasing availability of individual-level data and the rapid development of
machine learning methods have led to the application of individualized treatment rules (ITRs) in
a variety of fields, which assign different treatments to individuals based on their observed char-
acteristics. Examples include personalized medicine and micro-targeting in business and political
campaigns (e.g., Hamburg and Collins, 2010; Imai and Strauss, 2011). In the causal inference
literature, a number of researchers have developed methods to estimate ITRs, while others have
applied machine learning methods for estimating heterogeneous treatment effects, which can then
be used to construct ITRs.
Despite these advancements in methodological development and empirical applications, how-
ever, there exist few methods that empirically evaluate the performance of ITRs. In particular,
many existing ITR estimators based on machine learning methods do not come with statistical
uncertainty measures (e.g., Qian and Murphy, 2011; Zhao et al., 2012; Imai and Ratkovic, 2013;
Laber and Zhao, 2015; Fu, Zhou and Faries, 2016; Zhou et al., 2017; Ku¨nzel et al., 2018), while
others only provide asymptotic, model-based standard errors (e.g., Brinkley, Tsiatis and Anstrom,
2010; Cai et al., 2010; Zhang et al., 2012). In addition, some of the new methods for estimating
heterogeneous treatment effects rely on variants of bootstrap and Bayesian posterior sampling
methods to obtain uncertainty estimates about the conditional average treatment effects given
individual characteristics (e.g., Athey and Imbens, 2016; Hahn, Murray and Carvalho, 2017; Wa-
ger and Athey, 2018). Nevertheless, it is not immediately clear how conditional variances about
average treatment effects can be used to conduct inference for the population performance of
the ITRs. Finally, the results of the 2017 Atlantic Causal Inference Conference Data Analysis
Challenge suggest that these model-based and resampling-based confidence intervals may have
poor coverage in practice when estimating heterogeneous treatment effects (see Hahn, Dorie and
Murray, 2018, for details).
To address this problem, we propose to use the data from a randomized experiment for evalu-
ating the efficacy of ITRs. In particular, we consider common real-world settings, in which policy
makers wish to predict the performance of a given ITR prior to its administration in a target popu-
lation. Since an ITR of interest is given, we do not consider its estimation uncertainty concerning.
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Rather, the uncertainty comes from the fact that we do not know how the ITR would perform if
administered to the target population. Our methodology, which is based on the classical repeated
sampling approach of Neyman (1923), has several advantages over the existing methods. Specif-
ically, the proposed methodology does not depend on any modeling assumptions or asymptotic
approximations used to construct ITRs. It does not require computationally intensive methods
such as bootstrap, which could only capture the uncertainty across samples and not treatment.
In fact, the uncertainty estimates are based solely on the randomization of treatment assignment
and the random sampling of experimental units. As a result, it is applicable to the empirical
evaluation of ITRs derived from a wide range of statistical and machine learning methods.
We begin by introducing the Population Average Prescriptive Effect (PAPE) as one measure
of ITR’s efficacy (Section 2.2). The PAPE is defined as the difference between the average out-
comes under an ITR and the random treatment rule, which randomly selects the same number of
individuals to be treated as the number of indviduals treated under the ITR. Much of the existing
methodology literature uses the value or the average outcome under an ITR, as an evaluation met-
ric (e.g., Qian and Murphy, 2011; Zhao et al., 2012). In contrast, we argue that when evaluating
the efficacy of an ITR, it is important to hold the number of treated units constant. Otherwise,
if a treatment has a non-negative effect on all individuals, for example, we would conclude that
treating everyone will be an optimal strategy. While the PAPE has been used by others (e.g.,
Imai and Strauss, 2011; Rzepakowski and Jaroszewicz, 2012; Gutierrez and Ge´rardy, 2016; Fifield,
2018), a formal statistical analysis has not been conducted. We propose an unbiased estimator of
the PAPE and derive its variance.
We also consider the PAPE under a budget constraint (Section 2.3). As most policy makers
have a limited amount of resources, establishing the priority as to who should receive the treatment
is essential. Under this setting, we propose an approximately unbiased estimator of the PAPE and
its variance. Since the efficacy of an ITR can vary as a function of budget constraint, we define
the Area under the Prescriptive Effect Curve (AUPEC), which summarizes the relative advantage
of the ITR over the random treatment rule. The AUPEC averages the PAPE over a specified
range of budget constraint (Section 2.4). Again, we propose an approximately unbiased estimator
of the AUPEC and derive its variance.
As the third evaluation metric, we consider the Population Average Prescriptive Effect Differ-
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ence (PAPD), which quantifies the difference in the average outcome under two ITRs with the
same budget constraint (Section 2.5). Unlike the usual comparison based on the value of ITRs,
the PAPD holds the maximal proportion of treated units constant and hence puts two ITRs on
an equal footing. The PAPD also generalizes the PAPE as the latter is a comparison against the
random treatment rule. We propose an approximately unbiased estimator of the PAPD. Although
the repeated sampling variance of this estimator is unidentifiable, we derive its upper bound,
which yields a conservative estimate of the variance.
Next, we analytically compare the statistical efficiency of this ex-post experimental evaluation
over the ex-ante experimental evaluation, in which individuals are randomly assigned to either
an ITR or a random treatment rule (Section 2.6). Unfortunately, a definitive conclusion on the
statistical efficiency of two approaches is difficult to draw because the comparison depends on
many parameters. Nevertheless, we show that under a set of simplifying assumptions, the ex-post
experimental evaluation presented in this paper is statistically more efficient than the ex-ante
evaluation. One reason is that the ex-post evaluation utilizes the entire experimental sample to
estimate the average outcomes under both the ITR of interest and the random treatment rule
while the ex-ante evaluation uses a separate part of the sample for each treatment rule.
In Section 3, we conduct a simulation study to evaluate the ITRs based on three machine
learning methods — Bayesian Additive Regression Tree (Hahn, Murray and Carvalho, 2017),
Causal Forest (Wager and Athey, 2018), and LASSO (Tibshirani, 1996). The set up of our
simulation study follows that of the aforementioned 2017 Atlantical Causal Inference Conference
Data Challenge, in which the focus of the competition was the estimation of conditional average
treatment effect. We show that even in the sample size as small as 100 the confidence intervals
based on the proposed variance estimators have empirical coverage rates close to the nominal rates
for the proposed quantities of interest.
In Section 4, we apply the proposed methodology to the Tennessee’s Student/Teacher Achieve-
ment Ratio (STAR) Project, which experimentally examines the efficacy of small class on students’
performance. Using this experimental data, we show how to evaluate the ITRs based on the afore-
mentioned three machine learning methods. We find that these ITRs do not significantly improve
upon the random treatment rule when there is no budget constraint in part because small classes
have a non-negative effect on many students. However, when we impose a budget constraint, the
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ITRs based on BART and Causal Forest significantly outperforms the random treatment rule by
identifying a subset of students who benefit greatly from small class. Our analysis shows that
in this application the ITR based on Causal Forest performs best, followed by BART and then
LASSO.
Finally, Section 5 gives concluding remarks. We briefly discuss how the proposed evaluation
framework can be extended to other settings including dynamic optimal treatment regimes and
network experiments.
2 The Proposed Methodology
In this section, we describe the proposed methodology. We introduce four evaluation metrics for
ITRs, propose their estimators, and derive the bias and variance under the repeated sampling
framework of Neyman (1923). We also compare the statistical efficiency of ex-post experimental
evaluation with that of ex-ante experimental evaluation.
2.1 The Setup and Assumptions
Suppose that policy makers wish to predict the performance of a given individualized treatment
rule (ITR) f prior to its administration in a target population, P . Formally, we define the ITR as
a fixed and deterministic map from the covariate space to the binary treatment assignment (Qian
and Murphy, 2011; Zhao et al., 2012),
f : X −→ {0, 1}.
where X is the support of covariates X. We consider an experimental evaluation of the ITR. Since
the ITR is given, we do not consider its estimation uncertainty. Rather, the uncertainty comes
from the fact that we do not know how the ITR would perform if administered to the target
population.
Assume that we have a simple random sample of n units from the population of interest, P .
We conduct a completely randomized experiment in which n1 > 2 units are randomly assigned to
the treatment condition with probability n1/n and the rest of n0(= n− n1) units are assigned to
the control condition. Let Ti denote the treatment assignment indicator variable, which is equal to
1 if unit i is assigned to the treatment condition. For each unit, we observe the outcome variable
Yi ∈ Y as well as a vector of pre-treatment covariates, Xi ∈ X , where Y and X are the support
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of the outcome and covariates, respectively. We assume no interference between units and denote
the potential outcome for unit i under the treatment condition Ti = t as Yi(t) for t = 0, 1. Then,
the observed outcome is given by Yi = Yi(Ti).
We formally state these assumptions as follows.
Assumption 1 (No Interference between Units) The potential outcomes for unit i do not
depend on the treatment status of other units. That is, for all t1, t2, . . . , tn ∈ {0, 1}, we have,
Yi(T1 = t1, T2 = t2, . . . , Tn = tn) = Yi(Ti = ti)
Assumption 2 (Random Sampling of Units) Each of n units, represented by a three-tuple
consisting of two potential outcomes and pre-treatment covariates, is assumed to be independently
sampled from a super-population P, i.e.,
(Yi(1), Yi(0),Xi)
i.i.d.∼ P
Assumption 3 (Complete Randomization) For any i = 1, 2, . . . , n, the treatment assign-
ment probability is given by,
Pr(Ti = 1 | Yi(1), Yi(0),Xi) = n1
n
While it is straightforward to allow for unequal treatment assignment probabilities across units,
for the sake of simplicity, we assume complete randomization.
2.2 Evaluation against the Random Treatment Rule
Our goal is to evaluate the efficacy of an individualized treatment rule (ITR). In the literature,
researchers often evaluate the population average value (PAV) of an ITR (e.g., Qian and Murphy,
2011; Zhao et al., 2012; Zhang et al., 2012; Zhou et al., 2017), which is defined as the (super-
population) average potential outcome under the ITR,
λf = E{Yi(f(Xi))}.
We argue that when evaluating an ITR, it is important to consider the proportion of units which
are assigned to the treatment condition. Since a treatment is often costly in practice, the efficacy
of an ITR must be examined while holding the number of treated units constant. We do so by
comparing an ITR against the random treatment rule, which randomly selects the same number
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of treated units (see e.g., Imai and Strauss, 2011; Rzepakowski and Jaroszewicz, 2012; Gutierrez
and Ge´rardy, 2016; Fifield, 2018).
Formally, let pf = Pr(f(Xi) = 1) denote the proportion of units assigned to the treatment
condition under the individualized treatment assignment rule f , where we assume 0 < pf < 1.
Then, we can define the population average prescription effect (PAPE) of an ITR over the random
treatment rule as,
τf = E{Yi(f(Xi))− pfYi(1)− (1− pf )Yi(0)} (1)
where the PAV of the random treatment rule is given by E{pfYi(1)− (1− pf )Yi(0)}. We consider
the statistical inference about the PAPE from Neyman’s repeated sampling approach (Neyman,
1923). We propose the following estimator of the PAPE,
τˆf =
n
n− 1
[
1
n1
n∑
i=1
YiTif(Xi) +
1
n0
n∑
i=1
Yi(1− Ti)(1− f(Xi))− pˆf
n1
n∑
i=1
YiTi − 1− pˆf
n0
n∑
i=1
Yi(1− Ti)
]
(2)
where pˆf =
∑n
i=1 f(Xi)/n is an estimate of pf . The next theorem shows the unbiasedness of this
estimator and derives its variance.
Theorem 1 (Unbiasedness and Variance of the Proposed Estimator for the PAPE)
Under Assumptions 2– 3, the bias and variance of the estimator of the PAPE given in equation (2)
are given by,
E(τˆf − τf ) = 0
V(τˆf ) =
n2
(n− 1)2
[E(S2f1)
n1
+
E(S2f0)
n0
+
1
n2
{
τ 2f − npf (1− pf )τ 2 + 2(n− 1)(2pf − 1)τfτ
}]
where
τ = E(Yi(1)− Yi(0)) and S2ft =
1
n− 1
n∑
i=1
(Y ∗i (t)− Y ∗(t))2
for t = {0, 1}, Y ∗i (t) = (f(Xi)− pˆf )Yi(t), and Y ∗(t) =
∑n
i=1 Y
∗
i (t)/n.
Proof is given in Appendix A.1. Note that E(S2ft) 6= V(Y ∗i (t)) because the proportion of treated
units pf is unknown and estimated. The additional term in the variance accounts for the estimation
uncertainty of pf . In addition, the variance of the proposed estimator can be consistently estimated
by replacing the unknown terms, i.e., pf , τf , τ , E(S2ft), with their unbiased estimates, i.e., pˆf , τˆf ,
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and
τˆ =
1
n1
n∑
i=1
TiYi − 1
n0
n∑
i=1
(1− Ti)Yi, Ê(S2ft) =
1
nt − 1
n∑
i=1
1{Ti = t}(Y ∗i − Y ∗t )2.
where Y ∗i = (f(Xi)− pˆf )Yi and Y ∗t =
∑n
i=1 1{Ti = t}Y ∗i /nt.
2.3 Evaluation with a Budget Constraint
In many practical situations, the evaluation of ITRs requires the consideration of a budget con-
traint. The evaluation strategy discussed above assumes that there is no limit on the number of
individuals assigned to the treatment condition. Here, we operationalize a budget constraint as
the maximal proportion of treated units, denoted by p, and consider the setting, in which this
proportion is less than the proportion of units to be treated under an ITR, i.e., p < pf . Note that
if p ≥ pf , then a budget constraint is not binding and hence the results of Section 2.2 directly
apply.
With a budget constraint, we cannot simply treat all units who are predicted to benefit from
the treatment. Instead, an ITR must be based on a score function that orders units according to
their treatment priority. That is, a unit with a greater score has a higher priority to receive the
treatment. Let s : X −→ S be such a score function where S ⊂ R. For the sake of simplicity,
we assume that the score function is bijective, i.e., s(x) 6= s(x′) for any x,x′ ∈ X with x 6= x′.
This assumption is not restrictive as we can always redefine X such that the assumption holds. A
prominent example of score function is the conditional average treatment effect (CATE),
s(x) = E(Yi(1)− Yi(0) | Xi = x).
A number of researchers have studied how the CATE can be best estimated using various ma-
chine learning methods such as regularized regression models and tree-based methods (e.g., Imai
and Strauss, 2011; Qian and Murphy, 2011; Imai and Ratkovic, 2013; Athey and Imbens, 2016;
Grimmer, Messing and Westwood, 2017; Ku¨nzel et al., 2018; Wager and Athey, 2018).
We now define an ITR based on a score function by assigning a unit to the treatment group if
and only if its score is higher than a threshold, cp
f(Xi, cp) = 1{s(Xi) > cp}.
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Since we are considering the case with a binding budget constraint, the threshold cp corresponds
to the maximal proportion of treated units under the budget constraint, i.e.,
cp = inf{c ∈ R : Pr(f(Xi, c) = 1) ≤ p}.
Following the idea discussed above, we evaluate an ITR f against the random treatment rule,
which randomly selects p proportion of units for the treatment group. Thus, we define the PAPE
with a budget constraint p as,
τf (cp) = E{Yi(f(Xi, cp))− pYi(1)− (1− p)Yi(0)}. (3)
We consider the following estimator of the PAPE with a budget constraint,
τˆf (cˆp) =
1
n1
n∑
i=1
YiTif(Xi, cˆp)+
1
n0
n∑
i=1
Yi(1−Ti)(1−f(Xi, cˆp))− p
n1
n∑
i=1
YiTi− 1− p
n0
n∑
i=1
Yi(1−Ti)
(4)
where cˆp = inf{c ∈ R :
∑n
i=1 f(Xi, c) ≤ np}. As before, we examine the bias and variance under
Neyman’s repeated sampling framework. ince we are also estimating cp, the bias of the proposed
estimator in equation (4) is not zero. However, we can derive its upper bound.
Theorem 2 (Bias and Variance of the Proposed Estimator for the PAPE with
a Budget Constraint) Under Assumptions 2– 3, the bias of the proposed estimator of the
PAPE with a budget constraint p defined in equation (4) can be bounded as follows,
P(|E{τˆf (cˆp)−τf (cp)}| ≥ ) ≤ 1−B(p+γp(), bnpc, n−bnpc+1)+B(p−γp(), bnpc, n−bnpc+1)
where any given constant  > 0, B(, α, β) is the incomplete beta function, and
γp() =

maxc∈[cp−, cp+] E(Yi(1)− Yi(0) | s(Xi) = c)
,
The variance of the estimator is given by,
V(τˆf (cˆp)) =
E(S˜2f1)
n1
+
E(S˜2f0)
n0
+
bnpc(n− bnpc)
n2(n− 1)
{
(2p− 1)κ1(Xi, cˆp)2 − 2pκ1(Xi, cˆp)κ0(Xi, cˆp)
}
where, for t = 0, 1,
S˜2ft =
1
n− 1
n∑
i=1
(Y˜i(t)− Y˜ (t))2, κt(Xi, cˆp) = E(Yi(1)− Yi(0) | f(Xi, cˆp) = t),
Y˜i(t) = (f(Xi, cˆp)− p)Yi(t), and Y˜ (t) =
∑n
i=1 Y˜i(t)/n.
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Proof is given in Appendix A.2. Similar to PAPE, E[S˜2ft] 6= V[Y˜i(t)] due to the need to estimate
cp. The additional term in the variance accounts for the variance due to estimating cp. As before,
the variance can be consistently estimated by replacing each unknown parameter with its sample
analogue, i.e., for t = 0, 1,
Ê(S˜2ft) =
1
nt − 1
n∑
i=1
1{Ti = t}(Y˜i − Y˜t)2 (5)
̂κt(Xi, cˆp) =
∑n
i=1 1{f(Xi, cˆp) = t}TiYi∑n
i=1 1{f(Xi, cˆp) = t}Ti
−
∑n
i=1 1{f(Xi, cˆp) = t}(1− Ti)Yi∑n
i=1 1{f(Xi, cˆp) = t}(1− Ti)
(6)
where Y˜i = (f(Xi, cˆp) − p)Yi and Y˜ t =
∑n
i=1 1{Ti = t}Y˜i/nt. To estimate the term that appears
in the denominator of γp() as part of the upper bound of bias, we may assume that the CATE
E(Yi(1) − Yi(0) | s(Xi) = c) is Lipschitz continuous in c. The Lipschitz continuity of the CATE
is often assumed when estimating heterogeneous treatment effects (see e.g., Ku¨nzel et al., 2018;
Wager and Athey, 2018).
2.4 Area Under Prescriptive Effect Curve (AUPEC)
The PAPE defined in equation (3) varies as a function of budget constraint. Figure 1 shows this
graphically where the horizontal and vertical axes represent the budget and the average outcome,
respectively. In the figure, the red solid curve corresponds to the average outcome under an ITR,
i.e., E{Yi(f(Xi, cp)}, as a function of budget constraint p, whereas the black solid line represents
the average outcome under the random treatment rule. We may wish to evaluate the overall
efficacy of an ITR by computing the area under the red curve minus the area under the black
curve. This is shown as a shaded area in Figure 1, and we call it the Area Under the Prescriptive
Effect Curve (AUPEC). Formally, we define the AUPEC as,
Γf =
∫ pf
0
E{Yi(f(Xi, cp))}dp+ (1− pf )E{Yi(f(Xi, cpf ))} −
1
2
E(Yi(0) + Yi(1)).
Thus, the AUPEC represents the average performance relative to the random treatment rule
over the entire range of budget constraint. Although a similar idea is proposed in the literature
(see e.g., Rzepakowski and Jaroszewicz, 2012), unlike the previous work, we do not require an
individualized treatment rule to assign the maximal number of units to the treatment condition
under a budget constraint. For example, treating more than a certain proportion of units may
reduce the average outcome because these additional units do not benefit from the treatment.
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Budget, p
Average outcome
E[Yi(0)]
E[Yi(1)]
E[Yi(f(Xi, c1/n))]
E[Yi(f(Xi, c2/n))]
1
n
2
n
pf
Figure 1: The Area Under the Prescriptive Effect Curve (AUPEC). The black solid line represents
the average outcome under an individualized treatment rule while the red solid line represents the
average outcome under the random treatment rule. The shaded area between the curve and the
line corresponds to the AUPEC.
This is indicated by the flatness of the red line after pf in Figure 1. Recall that pf represents
the the maximal proportion of units an ITR f would assign to the treatment under no budget
constraint, i.e., pf = Pr(f(Xi) = 1). A large value of the AUPEC implies that the ITR under
consideration is effective when compared to the random treatment rule.
Now, let nf represent the maximum number of units the individual treatment rule f would
assign under no budget constraint, i.e., pˆf = nf/n =
∑n
i=1 f(Xi)/n. Then, we propose the
following estimator of the AUPEC,
Γ̂f =
1
n1
n∑
i=1
YiTi
{
1
n
(
nf∑
k=1
f(Xi, cˆk/n) + (n− nf )f(Xi, cˆnf/n)
)}
+
1
n0
n∑
i=1
Yi(1− Ti)
{
1− 1
n
(
nf∑
k=1
f(Xi, cˆk/n) + (n− nf )f(Xi, cˆnf/n)
)}
− 1
2n1
n∑
i=1
YiTi − 1
2n0
n∑
i=1
Yi(1− Ti) (7)
where cˆp = inf{c ∈ R :
∑n
i=1 f(Xi, c)/n ≤ p}. The following theorem bounds the bias and derives
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the variance of this estimator under Neyman’s repeated sampling approach.
Theorem 3 (Bias and Variance of the Proposed Estimator for the AUPEC) Under
Assumptions 2– 3, the bias of the estimator given in equation (7) can be bounded as follows,
P(|E(Γ̂f − Γf )| ≥ ) ≤ 1−B(pf + γpf (), bnpfc, n− bnpfc+ 1) +B(pf − γpf (), bnpfc, n− bnpfc+ 1)
where any given constant  > 0, B(, α, β) is the incomplete beta function, and
γpf () =

2 maxc∈[cpf−, cpf+] E(Yi(1)− Yi(0) | s(Xi) = c)
.
The variance is given by,
V(Γ̂f ) = E
[
− 1
n
{
Z∑
k=1
k(n− k)
n2(n− 1)κ1(Xi, cˆk/n)κ0(Xi, cˆk/n) +
Z(n− Z)2
n2(n− 1) κ1(Xi, cˆZ/n)κ0(Xi, cˆZ/n)
}
− 2
n4(n− 1)
Z−1∑
k=1
Z∑
k′=k+1
k(n− k′)κ1(Xi, cˆk/n)κ1(Xi, cˆk′/n)
−Z
2(n− Z)2
n4(n− 1) κ1(Xi, cˆZ/n)
2 − 2(n− Z)
2
n4(n− 1)
Z∑
k=1
kκ1(Xi, cˆZ/n)κ1(Xi, cˆk/n)
+
1
n4
Z∑
k=1
k(n− k)κ1(Xi, cˆk/n)2
]
+V
(
Z∑
i=1
i
n
κ1(Xi, cˆi/n) +
(n− Z)Z
n
κ1(Xi, cˆZ/n)
)
+
E(S†2f1)
n1
+
E(S†2f0)
n0
where Z is a Binomial random variable with size n and success probability pf , and for t = 0, 1,
S†2ft =
1
n− 1
n∑
i=1
(Y †i (t)− Y †(t))2, κt(Xi, cˆk/n) = E(Yi(1)− Yi(0) | f(Xi, cˆk/n) = t),
with Y †i (t) =
[
1
n
{∑nf
k=1 f(Xi, cˆk/n) + (n− nf )f(Xi, cˆnf/n)
}− 1
2
]
Yi(t) and Y †(t) =
∑n
i=1 Y
†
i (t)/n.
Proof is given in Appendix A.3. Here E[S†ft] 6= V[Y †i (t)] due to the need to estimate the terms ck/n
for all k, and the additional terms account for the variance of estimation. As discussed at the end
of Section 2.3, we can consistently estimate the upper bound of bias by assuming that the CATE
is Lipschitz continuous. As before, the variance can be consistently estimated by replacing each
unknown parameter with its sample analogue, i.e., for t = 0, 1,
Ê(S†2ft) =
1
nt − 1
n∑
i=1
1{Ti = t}(Y †i − Y †t )2 (8)
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̂κt(Xi, cˆk/n) =
∑n
i=1 1{f(Xi, cˆk/n) = t}TiYi∑n
i=1 1{f(Xi, cˆk/n) = t}Ti
−
∑n
i=1 1{f(Xi, cˆk/n) = t}(1− Ti)Yi∑n
i=1 1{f(Xi, cˆk/n) = t}(1− Ti)
(9)
where Y †i =
[
1
n
{∑nf
k=1 f(Xi, cˆk/n) + (n− nf )f(Xi, cˆnf/n)
}− 1
2
]
Yi and Y † =
∑n
i=1 Y
†
i /n. In the
extreme cases with k → 1 for t = 1 and k → n for t = 0, the denominators in equation (9) are
likely to be close to zero. In such cases, we instead use the estimator ̂κ1(Xi, cˆkmin/n) for all k < kmin
where kmin is the smallest k such that equation (9) for κ1(Xi, cˆk/n) does not suffer from zero in
the denominators. Similarly, for t = 0, we use ̂κ0(Xi, cˆkmax/n) for all k > kmax where kmax is the
largest k such that equation (9) does not suffer from zero in the denominators.
For the terms involving the binomial random variable Z, we first note that these terms when
fully expanded out are the polynomials of pf = E(f(Xi)). To estimate the polynomials of pf ,
we can utilize their unbiased estimators as discussed in Stuard and Ord (1994), i.e., pˆkf = s(s −
1) · · · (s−k+ 1)/{n(n− 1) · · · (n−k+ 1)}} where s = ∑ni=1 f(Xi) is unbiased for pkf for all k ≤ n.
When the sample size is large, this estimation method is not computationally efficient and stable
due to the presence of high powers. Hence, we may use the Monte Carlo sampling of Z from a
Binomial distribution with size n and success probability pˆf . In our simulation study, we show
that this Monte Carlo approach is effective (see Section 3).
2.5 Relative Efficacy of Two Individualized Treatment Rules
We may also be interested in evaluating the relative efficacy of two ITRs, f and g. This can be
done by estimating the difference in the population average value (PAV) between the two ITRs,
∆(f, g) = λf − λg = E{Yi(f(Xi))− Yi(g(Xi))}. (10)
While this quantity is useful in some settings, the problem is the same as the PAV itself; it fails
to take into account the number of units assigned to the treatment condition under each ITR.
For example, if a treatment never hurts units, i.e., Yi(1) ≥ Yi(0) for all i, then it is not fair to
compare an ITR that treats most of the individuals to another ITR that treats only a few. Such
a comparison would not account for how good each ITR is in identifying those who benefit most
from the treatment.
To address this issue, we compare the efficacy of two ITRs under a budget contraint. That is,
we aim to estimate the difference in the PAPEs under the same budget constraint p. Formally,
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we define the Population Average Prescriptive Effect Difference (PAPD) under budget p as,
∆p(f, g) = τf (cp)− τg(cp) = E{Yi(f(Xi, cp))− Yi(g(Xi, cp))}
We propose the following estimator of the PAPD,
∆̂p(f, g) =
1
n1
n∑
i=1
YiTi(f(Xi, cˆ
f
p)− g(Xi, cˆgp)) +
1
n0
n∑
i=1
Yi(1− Ti)(g(Xi, cˆgp)− f(Xi, cˆfp)) (11)
where cˆfp = inf{c ∈ R :
∑n
i=1 f(Xi, c) ≤ np} and cˆgp = inf{c ∈ R :
∑n
i=1 g(Xi, c) ≤ np}.
As before, we derive the bias and variance of this estimator under the Neyman’s repeated
sampling framework. Although the bias of the proposed estimator in equation (11) is not zero,
we derive its upper bound as done in Theorems 2 and 3. Unlike the previous results, however,
the variance is not identifiable either in this case. Hence, we derive its upper bound, yielding a
conservative variance estimator.
Theorem 4 (Bias and Variance of the Proposed Estimator for the PAPD with a
Budget Constraint) Under Assumptions 2–3, the bias of the proposed estimator of the PAPD
with a budget constraint p defined in equation (11) can be bounded as follows,
P(|E{∆̂p(f, g)−∆p(f, g)}| ≥ ) ≤ 1−2B(p+γp(), bnpc, n−bnpc+1)+2B(p−γp(), bnpc, n−bnpc+1)
where any given constant  > 0, B(, α, β) is the incomplete beta function, and
γp() =

maxc∈[cfp−, cfp+],d∈[cgp−, cgp+]{E(Yi(1)− Yi(0) | sf (Xi) = c),E(Yi(1)− Yi(0) | sg(Xi) = d)}
,
The variance of the estimator is bounded by,
V(∆̂p(f, g)) ≤
E(S2fg1)
n1
+
E(S2fg0)
n0
+
bnpc(bnpc − n)
n2(n− 1)
(
κf1(Xi, cˆ
f
p)
2 + κg1(Xi, cˆ
g
p)
2
)
+2
bnpcmax{bnpc, n− bnpc}
n2(n− 1)
∣∣∣κf1(Xi, cˆfp)κg1(Xi, cˆgp)∣∣∣
where for t = 0, 1, κft (Xi, cˆ
f
p) = E(Yi(1) − Yi(0) | f(Xi, cˆfp) = t), κgt (Xi, cˆgp) = E(Yi(1) − Yi(0) |
g(Xi, cˆ
g
p) = t),
S2fgt =
1
n− 1
n∑
i=1
(Y˜ ∗i (t)− Y˜ ∗(t))2,
Y˜ ∗i (t) =
(
f(Xi, cˆ
f
p)− g(Xi, cˆgp)
)
Yi(t) and Y˜ ∗(t) =
∑n
i=1 Y˜
∗
i (t)/n.
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Proof is given in Appendix A.4. The upper bound of the variance can be estimated by replac-
ing the unknown parameters with their sample analogues in a manner similar to those given in
equations (5) and (6). Unlike the case of the PAPE under a budget constraint (see Theorem 2),
the variance of the PAPD estimator under a budget constraint is unidentifiable. In the previous
case, we have only score sf (X), and the statistic cˆ
f
p helps us anchor its distribution because of the
identity, Pr(sf (X) > cˆ
f
p) = bnpc/n. In the current case, however, we have two scores, cˆfp and cˆgp.
Unfortunately, we can only identify their marginal distributions from the observed data, and their
joint distribution is unidentifiable.
2.6 Comparison with the Ex-ante Experimental Evaluation
So far, we have considered an ex-post evaluation, in which we first conduct a randomized experi-
ment and then evaluate ITRs using the data from the experiment. Alternatively, researchers may
consider an ex-ante experimental evaluation, in which we conduct a randomized experiment to
directly evaluate ITRs. We compare the ex-ante and ex-post evaluations in terms of their statis-
tical efficiency. Intuitively, the ex-post evaluation is likely to be more efficient because the entire
sample is used to estimate the PAV for both the ITR of interest and a random assignment rule. In
contrast, the ex-ante evaluation uses separate parts of the sample for the estimation of the PAV
for the two treatment rules. Although it is difficult to draw a definitive conclusion, the result of
our analysis below confirms this intuition.
Suppose we have a simple random sample of n units from the same target population, P .
Consider a completely randomized experiment, in which a total of nf > 2 units are randomly
assigned to an ITR f while the remaining units nr = n−nf are assigned to the random treatment
rule with the probability of treatment assignment equal to nr1/nr. Let Fi be an indicator variable,
which is equal to 1 if unit i is assigned to the ITR f and is equal to 0 otherwise. Under the random
treatment rule, the number of units that are randomly assigned to the treatment condition is nr1
while nr0 = nr − nr1 units are assigned to the control condition. As before, we use Ti to represent
the treatment indicator.
Assumption 4 (Complete Randomization in the Ex-ante Evaluation) For any i = 1, 2, . . . , n,
the probability of being assigned to the individualized treatment rule rather than the random treat-
ment rule is given by,
Pr(Fi = 1 | Yi(1), Yi(0),Xi) = nf
n
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Among those who are assigned to the random treatment rule, i.e., Fi = 0, the probability of
treatment assignment is given by,
Pr(Ti = 1 | Yi(1), Yi(0),Xi, Fi = 0) = nr1
nr
Using this experimental data, we wish to estimate the PAPE defined in equation (1). One
potential complication is that we have to adjust for the number of treated units as done throughout
this paper since the number of treated units under the random treatment rule may differ from
that under the ITR, i.e., pˆf 6= nr1/nr where pˆf =
∑n
i=1 f(Xi)/n. On the other hand, it is
possible to choose the number of treated units under the random treatment rule such that the
equality is enforced if the covariate data for the group assigned to the ITR are available before
the randomization of treatment assignment. We propose the following estimator of the PAPE
for the ex-ante experimental evaluation that accounts for a potential difference in the proportion
of treated units between the ITR and the random treatment rule by appropriately weighting the
latter,
τˆ ∗f =
n
n− 1
(
1
nf
n∑
i=1
Fif(Xi)Yi − pˆf
nr1
n∑
i=1
(1− Fi)TiYi − 1− pˆf
nr0
n∑
i=1
(1− Fi)(1− Ti)Yi
)
(12)
The ex-ante evaluation differs from the ex-post evaluation in two ways. First, the ex-ante esti-
mator requires two separate randomizations (Ti and Fi) while the ex-post estimator only involves
one. Intuitively, an additional layer of randomization increases variance. Second, the ex-ante
evaluation requires a separate group that follows an ITR, whereas all individuals in the ex-post
evaluation are simply randomly assigned either to the treatment or control group. As a result, in
the ex-post evaluation, the PAV of the random treatment rule is estimated using the entire sample.
Together, we expect the ex-ante evaluation to be less efficient than the ex-post evaluation. We
confirm this intuition under a set of simplifying assumptions below.
Before comparing two modes of evaluation, we derive the bias and variance of the ex-ante
estimator under Neyman’s repeated sampling framework. In the current case, the uncertainty
comes from three types of randomness: (1) the random assignment to the individualized or random
treatment rule, (2) the randomized treatment assignment under the random assignment rule, and
(3) the simple random sampling of units from the target population. The next theorem shows
that this estimator is unbiased and the variance is identifiable.
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Theorem 5 (Bias and Variance of the Proposed Ex-Ante Estimator for PAPE) Under
Assumptions 2, 1, and 4, the bias and variance of the estimator of the PAPE given in equation (12)
are given by,
E(τˆ ∗f − τf ) = 0
V(τˆ ∗f ) =
n2
(n− 1)2
[
E
{
S2f
nf
+
pˆ2fS
2
1
nr1
+
(1− pˆf )2S20
nr0
}
+
1
n2
{
τ 2f − npf (1− pf )τ 2 + 2(n− 1)(2pf − 1)τfτ
}]
where
S2f =
1
n− 1
n∑
i=1
(Yi(f(Xi))− Y (f(X)))2, S2t =
1
n− 1
n∑
i=1
(Yi(t)− Y (t))2
for t = 0, 1.
Proof is given in Appendix A.5. To estimate the variance, we replace the terms with their unbiased
estimates.
We now examine the relative statistical efficiency of the ex-post and ex-ante experimental
evaluations. This can be done by directly comparing the variances derived in Theorems 1 and 5.
To facilitate the comparison, we assume n1 = n0 = nf = nr = n/2. In words, the ex-ante
evaluation sets the treatment assignment probability to 1/2, and the ex-post evaluation also sets
the probability of being assigned to the ITR to 1/2. Finally, we also assume nr1 = nr0 = n/4,
implying that in the ex-post evaluation the treatment assignment probability under the random
treatment rule also equals 1/2. Under this setting, the difference in the variance of the PAPE
estimator between the ex-ante and ex-post evaluations is given by,
V(τˆ ∗f )− V(τˆf )
=
2n
(n− 1)2
[
E
{
p2fS
2
1 + (1− pf )2S20
}
+ 2 Cov(f(Xi)Yi(1), (1− f(Xi))Yi(0))
+ 2pf Cov(f(Xi)Yi(1), Yi(1)) + 2(1− pf ) Cov((1− f(Xi))Yi(0), Yi(0))]
=
2n
(n− 1)2
[
p2fV(Yi(1)) + (1− pf )2V(Yi(0))− 2pf (1− pf )E(Yi(0) | f(Xi) = 0)E(Yi(1) | f(Xi) = 1)
+2p2f
{
E(Y 2i (1) | f(Xi) = 1)− E(Yi(1))E(Yi(1) | f(Xi) = 1)
}
+2(1− pf )2
{
E(Y 2i (0) | f(Xi) = 0)− E(Yi(0))E(Yi(0) | f(Xi) = 0)
}]
(13)
The details of the derivation are given in Appendix A.6.1.
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Suppose now that the ITR correctly assigns individuals on average, i.e., E(Yi(t) | f(Xi) = t) ≥
E(Yi(t) | f(Xi) = 1 − t) for t = 0, 1. Under this assumption, the last two terms in the square
bracket are positive, i.e.,
E(Y 2i (t) | f(Xi) = t)− E(Yi(t))E(Yi(t) | f(Xi) = t) ≥ V(Yi(t) | f(Xi) = t)
for t = 0, 1. Hence, the only term that is possibly negative in equation (13) is the third term in the
square bracket. This suggests that the ex-post evaluation is more efficient than ex-ante evaluation
if this term is sufficiently small.
Unfortunately, it is difficult to generally determine the sign of this variance difference. One
reason for this difficulty is that the proposed ex-post evaluation estimator τˆf in equation (2) is
not invariant to a constant shift of the outcome variable due to the fact that pf is estimated.
That is, adding a constant δ to Y will change the value of τˆf . Although this does not change the
unbiasedness of τˆf , it does alter the variance shown in Theorem 1. Specifically, the variance will
have an additional term:
2pf (1− pf )
[
δ2 + {(1− pf )E(Yi(1) + Yi(0) | f(Xi) = 1) + pfE(Yi(1) + Yi(0) | f(Xi) = 0)}δ
]
It is natural to choose the value of δ to minimize this extra term of the variance, which yields the
following optimal value,
δ∗ = −1
2
{(1− pf )E(Yi(1) + Yi(0) | f(Xi) = 1) + pfE(Yi(1) + Yi(0) | f(Xi) = 0)} (14)
Roughly speaking, the optimal value of δ balances the two potential outcomes around zero after
a constant shift, i.e., 1
n
∑n
i=1{(Yi(1) + δ∗) + (Yi(0) + δ∗)}/2 ≈ 0.
Now, for simplicity, assume that E(Yi(1) + Yi(0) | f(Xi) = 1) = E(Yi(1) + Yi(0) | f(Xi) =
0) = 0. This guarantees that the optimal choice of δ is zero and hence no adjustment in variance
is necessary. Under this assumption, we can bound equation (13) from below as follows (see
Appendix A.6.2 for details),
V(τˆ ∗f )− V(τˆf )
=
2n
(n− 1)2
[
p2fV(Yi(1)) + (1− pf )2V(Yi(0)) + 2p2fV(Yi(1) | f(Xi) = 1) + 2(1− pf )2V(Yi(0) | f(Xi) = 0)
+2pf (1− pf )
[
(1− pf ){E(Yi(0) | f(Xi) = 0)}2 + pf{E(Yi(1) | f(Xi) = 1)}2
]]
≥ 0
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This implies that under this simplifying assumption the ex-post evaluation is more efficient than
the ex-ante evaluation. Thus, our analysis suggests that the ex-post evaluation may result in a
smaller variance than the ex-ante evaluation. At least, there is no clear reason to prefer the ex-ante
evaluation over the ex-post evaluation.
3 A Simulation Study
We conduct a simulation study to examine the finite sample performance of the proposed method-
ology. We show that the empirical coverage probability of the confidence interval based on the
proposed variance converges quickly to its nominal counterpart. We also find that as expected the
bias is minimal even when the proposed estimator is not unbiased and the variance bounds are
tight.
3.1 Data Generation Process
We base our data generating process (DGP) on the one used in the 2017 Atlantic Causal inference
Conference (ACIC) Data Analysis Challenge (see Hahn, Dorie and Murray, 2018, for details). The
focus of this competition was the estimation and inference for the conditional average treatment
effect in observational studies. A total of 8 covariates X are taken from the Infant Health and
Development Program (Brooks-Gunn, Liaw and Klebanov, 1992), which originally had 58 covari-
ates and n = 4, 302 observations. In our simulation, we assume that the population distribution
of covariates is equal to the empirical distribution based on this data set. Therefore, we obtain
each simulation sample via boostrap. We vary the sample size by setting it to either 100, 500, or
2,000.
We use the same outcome model as the one used in the competition,
E(Yi(t) | Xi) = µ(Xi) + τ(Xi)t (15)
where
pi(x) =
1
1 + e3(x1+x43+0.3(x10−1))−1
µ(x) = − sin(Φ(pi(x))) + x43
τ(x) = ξ(x3x24 + (x14 − 1)− (x15 − 1))
with Φ(·) representing the standard Normal CDF and xj indicating a specific covariate in the
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data set (see Hahn, Dorie and Murray, 2018). One important difference from the competition is
that we assume a complete randomized experiment whereas the original DGP used the treatment
assignment mechanism as a function of covariates. As in the original competition, we focus on
two scenarios regarding the treatment effect size by setting ξ equal to 2 (“high”) and 1/3 (“low”).
Although the original DGP included four different types of errors, we focus on the independently,
and identically distributed σ(Xi)i where σ(x) = 0.25
√
V(µ(x) + pi(x)τ(x)) and i
i.i.d.∼ N (0, 1).
For illustration, we evaluate the Bayesian Additive Regression Trees (BART) (see Chipman
et al., 2010; Hill, 2011; Hahn, Murray and Carvalho, 2017), which had the best overall performance
in the original competition. We also compare this model with two other popular methods: Causal
Forest, which is a variant of random forest designed specifically for the estimation of heterogeneous
causal effects (Wager and Athey, 2018) as well as the LASSO, which includes all main effect terms
and two-way interaction effect terms between the treatment and all covariates (Tibshirani, 1996).
All three models are trained on the original data from the 2017 ACIC Data Challenge. The
number of trees were tuned through the 5-fold cross validation for BART and Causal Forest. The
regularization parameter was tuned similarly for LASSO. All models were cross-validated on the
PAPE metric.
For implementation, we use R 3.4.2 with the following packages: bartMachine (version 1.4.2)
for BART, grf (version 0.10.2) for Causal Forest, and glmnet (version 2.0.13) for LASSO. Once the
models are trained, then an ITR is derived based on the magnitude of the estimated conditional
average treatment effect τˆ(x) under each model, i.e., f(Xi) = 1{τˆ(Xi) > 0}.
To compute the true value of our causal quantities of interest, we use the outcome model
specified in equation (15) and evaluate each quantity in the entire original data set. For example,
we compute the PAPE as,
τf =
1
n
n∑
i=1
{E(Yi(f(Xi)) | Xi)− pfE(Yi(1) | Xi)− (1− pf )E(Yi(0) | Xi)}
where pf =
∑n
i=1 f(Xi)/n. This computation gives the true value in our simulation setting because
we assume the population distribution of covariates is equal to the empirical distribution of the
original data set.
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n = 100 n = 500 n = 2000
Estimator true value coverage bias s.d. coverage bias s.d. coverage bias s.d.
Low treatment effect
τˆf 0.066 94.3% 0.005 0.124 96.2% 0.001 0.053 95.1% 0.001 0.026
τˆf (c0.2) 0.051 93.2 −0.002 0.109 94.4 0.001 0.046 95.2 0.002 0.021
Γ̂f 0.053 95.3 0.001 0.106 95.1 0.001 0.045 94.8 −0.001 0.024
∆̂0.2(f, g) −0.022 94.0 0.006 0.122 95.4 0.002 0.051 96.0 0.000 0.026
∆̂0.2(f, h) −0.014 93.9 −0.001 0.131 94.9 −0.000 0.060 95.3 −0.000 0.030
High treatment effect
τˆf 0.430 94.7% −0.000 0.163 95.7% 0.000 0.064 94.4% −0.000 0.031
τˆf (c0.2) 0.356 94.7 0.004 0.159 95.7 0.002 0.072 95.8 0.000 0.035
Γ̂f 0.363 94.3 −0.005 0.130 94.9 0.003 0.058 95.7 0.000 0.029
∆̂0.2(f, g) −0.000 96.9 0.008 0.151 97.9 −0.002 0.073 98.0 −0.000 0.026
∆̂0.2(f, h) 0.000 94.7 −0.004 0.140 97.7 −0.001 0.065 96.6 0.000 0.033
Table 1: The Results of the Simulation Study. The table presents the estimated bias and standard
deviation of each estimator as well as the estimated coverage of its 95% confidence intervals under
the “Low treatment effect” and “High treatment effect” scenarios. The first three estimators
shown here are for BART f : Population Average Prescription effect (PAPE; τˆf ), PAPE with
a budget constraint of 20% treatment proportion (τˆf (c0.2)), Area Under the Prescriptive Effect
Curve (AUPEC; Γ̂f ). We also present the results for the difference in the PAPE between BART
and Causal Forest g (∆̂0.2(f, g)) and between BART and LASSO h (∆̂0.2(f, g)) under the budget
constraint.
3.2 Results
Table 1 presents the estimated bias and standard deviation of each estimator as well as the
estimated coverage probability of its 95% confidence intervals based on the normal approximation.
These estimates are based on 1,000 Monte Carlo trials following the procedure described above.
The results are shown separately for two scenarios: high and low treatment effects. Under each
scenario, we use three different sample sizes. We first estimate the PAPE for BART τf without a
budget constraint. We also estimate the PAPE with a budget constraint of 20% as the maximal
proportion of treated units, τf (c0.2). Finally, we estimate the AUPEC for BART Γf . In addition,
we compare the performance of BART with the other methods by computing the difference in the
PAPE or PAPD between BART and Causal Forest (∆(f, g)), and between BART and LASSO
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Figure 2: Comparison of Ex-Post and Ex-ante PAPE Estimation for the Individualized Treatment
Rule based on BART. The standard deviation of the PAPE estimator for the ex-ante evaluation
(horizontal axis) is plotted against that for the ex-post evaluation (vertical axis). Two lines
represent different scenarios (low and high treatment effect), and each node represents a different
sample size.
(∆(f, h)). We find that under both scenarios and across sample sizes, the bias of our estimator is
small. Moreover, the coverage rate of 95% confidence intervals is close to their nominal rate even
when the sample size is quite small. Although we can only bound the variance when estimating
the PAPD between two ITRs (i.e., ∆0.2(f, g) and ∆0.2(f, h)), the estimated coverage stay close to
95%.
We next compare the relative efficiency between the ex-ante and ex-post experimental eval-
uations using the analytical results in Section 2.6. The simulation data we use for the ex-ante
evaluation are identical to those used for the ex-post evaluation so that we can make a fair com-
parison. We assign the half of the sample to the ITR and the other half to the random treatment
rule, i.e., nf = nr = n/2. Within the random treatment rule arm, the probability of receiving
the treatment is 50%, which is identical to the treatment assignment probability for the ex-post
evaluation, i.e., nr1/nr = nr0/nr = n1/n = n0/n = 1/2.
Figure 2 presents the result of the comparison for BART by plotting the standard deviation
of the PAPE estimator for the ex-ante evaluation (horizontal axis) against that for the ex-post
evaluation (vertical axis). We do not present the results for Causal Forest and LASSO as they are
21
sufficiently similar. For both low (red line with solid circles) and high (blue line with solid squares)
treatment effect scenarios, the ex-post evaluation estimator is much more efficient than the ex-ante
evaluation estimator. This finding is consistent with the analytical result derived under a set of
simplifying assumptions in Section 2.6.
4 An Empirical Application
We apply the proposed methodology to the data from the Tennessee’s Student/Teacher Achieve-
ment Ratio (STAR) project, which was a four-year longitudinal study experimentally evaluating
the impacts of class size in early education on various outcomes (Mosteller, 1995). We find that
Causal Forest generally outperforms BART and LASSO in this application.
4.1 Data and Setup
The STAR project randomly assigned over 7,000 students across 79 schools to three different
groups: small class (13 to 17 students), regular class (22 to 25 students), and regular class with a
full-time teacher’s aid. The experiment began when students entered kindergarden and continued
through third grade. Since our methodology is applicable only to a binary treatment (an extension
to a non-binary treatment is possible but is beyond the scope of this paper), we focus on the first
two groups: small class and regular class without an aid. The treatment effect heterogeneity is
important here because reducing class size is costly, requiring additional teachers and classrooms.
Policy makers who face a budget constraint may be interested in finding out which groups of
students benefit most from small class so that the priority can be given to those students.
We use a total of 10 pre-treatment covariates Xi that include four demographic characteristics
of students (gender, race, birth month, birth year) and six school characteristics (urban/rural,
enrollment size, grade range, number of students on free lunch, number of students on school
buses, and percentage of white students). Our treatment variable is the class size to which they
were assigned at kindergarten: small class Ti = 1 and regular class without an aid Ti = 0. For the
outcome variables Yi, we use three standardized test scores measured at third grade: SAT math,
reading, and writing scores.
The resulting data set has a total of 1,911 observations. We randomly select approximately
70% of the sample (i.e., 1,338 observations) as the training data and the reminder of the sample
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BART Causal Forest LASSO
est. s.e. treated est. s.e. treated est. s.e. treated
No budget constraint
SAT Math −6.50 4.30 85.9% −1.82 4.68 78.9% −16.43 4.67 78.7%
SAT Reading 1.32 2.93 97.0 −19.36 4.41 84.5 −0.87 4.41 84.4
SAT Writing 6.32 4.68 79.0 −6.85 4.82 76.4 2.21 4.67 80.0
Budget constraint
SAT Math 30.57 4.64 20% 39.88 4.65 20% −13.72 4.60 20%
SAT Reading 15.84 4.61 20 47.18 4.63 20 14.84 4.61 20
SAT Writing 23.76 4.69 20 32.64 4.70 20 −1.64 4.67 20
Table 2: The Estimated Population Average Prescription Effect (PAPE) for BART, Causal For-
est, and LASSO with and without a Budget Constraint. For each of the three outcomes, the
point estimate, the standard error, and the proportion treated are shown. The budget constraint
considered here implies that the maximum proportion treated is 20%.
(i.e., 573 observations) as the evaluation data. We train the same three machine learning models
as the ones used in our simulation study. For Causal Forest, we set tune.parameters = TRUE.
For BART, tuning was done on the number of trees. For LASSO, we tuned the regularization
parameter. All tuning were done through the 5-fold cross validation procedure on the training
set using the PAPE as the evaluation metric. We then create an ITR as 1{τˆ(x) > 0} where τˆ(x)
is the estimated conditional average treatment effect obtained from each fitted model. We will
evaluate these ITRs using the evaluation sample.
4.2 Results
The upper panel of Table 2 presents the estimated PAPE for the ITRs based on BART, Causal
Forest, and LASSO without a budget constraint. We find that without a budget constraint,
none of the ITRs based on the machine learning methods significantly improves upon the random
treatment rule with two exceptions. The ITR based on Causal Forest performs worse than the
random treatment rule for the SAT reading score by more than 19 points (with the standard error
of 4.4 points). In addition, the ITR based on LASSO also does worse for the SAT math score by
about 16 points (with the standard error of 4.7 points) relative to the random treatment rule.
The results change substantially when we impose a budget constraint. The lower panel of
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Table 2 presents the results with a budget constraint where the maximum proportion of treated
units is 20%. We find that the ITR derived from Causal Forest performs best across all three
outcomes. The ITR based on BART performs well though the amount of improvement over the
random treatment rule is less than that for the ITR based on Causal Forest. Finally, although
the ITR based on LASSO performs better than the random treatment rule for the SAT reading
score, this ITR is outperformed by the random treatment rule for the SAT math score.
Table 3 directly compares these three ITRs based on Causal Forest, BART, and LASSO by
estimating the Population Average Prescriptive Effect Difference (PAPD) under the same budget
constraint as above. We find that Causal Forest statistically significantly outperforms BART and
LASSO in essentially all cases (the exception is SAT writing for BART but its 95% confidence
interval only slightly overlaps with zero). Lastly, the difference between BART and LASSO is
statistically significant for SAT math and writing scores.
Finally, Figure 3 presents the estimated PAPE (solid red line) across a range of budget con-
straint with pointwise 95% confidence intervals. The area between this line and the black hori-
zontal line at zero corresponds to the Area Under the Prescriptive Effect Curve (AUPEC) (see
Figure A1 in Appendix A.7 for the plots showing the corresponding estimated Prescriptive Effect
Curves). The results are shown for the ITRs based on BART (left column), Causal Forest (middle
column), and LASSO (right column) and for each test score (rows). In each plot, the horizontal
axis represents the budget constraint as the maximum proportion treated, and the point estimate
and standard error of the AUPEC are shown.
We find that across three test scores both BART and Causal Forest find students who benefit
Causal Forest BART
vs. BART vs. LASSO vs. LASSO
est. 95% CI est. 95% CI est. 95% CI
SAT Math 9.31 [0.12, 18.50] 53.60 [44.31, 62.89] 44.29 [35.02, 53.56]
SAT Reading 31.34 [22.28, 40.40] 32.34 [23.62, 41.06] 1.00 [−7.82, 9.82]
SAT Writing 8.88 [−0.01, 17.78] 34.28 [25.46, 43.10] 25.40 [16.93, 33.87]
Table 3: The Estimated Population Average Prescriptive Effect Difference (PAPD) between In-
dividualized Treatment Rules based on Causal Forest, BART, and LASSO under a Budget Con-
straint. The point estimates and 95% confidence intervals are shown.
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AUPEC = 23.60 (s.e. = 4.02) AUPEC = 20.00 (s.e. = 4.14) AUPEC = -6.20 (s.e. = 4.13)
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Figure 3: Estimated Area Under the Prescriptive Effect Curve (AUPEC). A solid red line in
each plot represents the Population Average Prescriptive Effect (PAPE) across a range of budget
constraint (horizontal axis) with pointwise 95% confidence interval. The area between this line
and the black horizontal line at zero corresponds to the AUPEC. The results are presented for
the individualized treatment rules based on BART (left column), Causal Forest (middle column),
and LASSO (right column), whereas each row presents the results for a different outcome.
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positively from small class when the maximum proportion treated is relatively small. In contrast,
LASSO has a difficulty in identifying these individuals. Unfortunately, as the budget constraint
is relaxed, the ITRs based on BART and Causal Forest yields the PAPE similar to the one under
the random assignment rule. This suggests that they are “over-treating” students, meaning that
those who do not necessarily benefit from small class are also treated when little or no budget
constraint is imposed.
5 Concluding Remarks
As the application of individualized treatment rules (ITRs) becomes more widespread in a variety
of fields including medicine, business, and politics, a rigorous perfomance evaluation of ITRs
becomes essential before policy makers deploy an ITR in a target population. We believe that
the inferential approach proposed in this paper provides a robust and widely applicable tool to
empirically evaluate the efficacy of ITRs. Furthermore, we provide evidence that ex-post evaluation
of ITRs is more efficient than ex-ante evaluation. This opens up opportunities to utilize the existing
randomized controlled trial data for the efficient evaluation of ITRs before they are administered in
the real world. In addition, although we do not focus on the estimation of ITRs in this paper, the
proposed evaluation metrics can be used to tune hyper-parameters when cross validating machine
learning algorithms as done in our empirical application. In future research, we plan to consider
the extensions of the proposed methodology to other settings, including non-binary treatments,
dynamic treatments, and treatment allocations in the presence of interference between units.
26
References
Athey, Susan and Guido Imbens. 2016. “Recursive Partitioning for Heterogeneous Causal Effects.”
Proceedings of the National Academy of Sciences 113:7353–7360.
Bohrnstedt, George W. and Arthur S. Goldberger. 1969. “On the Exact Covariance of Products
of Random Variables.” Journal of the American Statistical Association 64:1439–1442.
Brinkley, Jason, Anastasios Tsiatis and Kevin J Anstrom. 2010. “A generalized estimator of the
attributable benefit of an optimal treatment regime.” Biometrics 66:512–522.
Brooks-Gunn, Jeanne, Fong-ruey Liaw and Pamela Kato Klebanov. 1992. “Effects of early inter-
vention on cognitive function of low birth weight preterm infants.” The Journal of pediatrics
120:350–359.
Cai, Tianxi, Lu Tian, Peggy H Wong and LJ Wei. 2010. “Analysis of randomized comparative
clinical trial data for personalized treatment selections.” Biostatistics 12:270–282.
Chipman, Hugh A, Edward I George, Robert E McCulloch et al. 2010. “BART: Bayesian additive
regression trees.” The Annals of Applied Statistics 4:266–298.
Fifield, Benjamin. 2018. Empirical and Computational Methods for Electoral Politics PhD thesis
Princeton University.
Fu, Haoda, Jin Zhou and Douglas E Faries. 2016. “Estimating optimal treatment regimes via
subgroup identification in randomized control trials and observational studies.” Statistics in
medicine 35:3285–3302.
Grimmer, Justin, Solomon Messing and Sean J. Westwood. 2017. “Estimating Heterogeneous
Treatment Eects andthe Eects of Heterogeneous Treatments with Ensemble Methods.” Political
Analysis 25:413–434.
Gutierrez, Pierre and Jean-Yves Ge´rardy. 2016. Causal Inference and Uplift Modelling: A Review
of the Literature. In Proceedings of Machine Learning Research, ed. Claire Hardgrove, Louis Do-
rard, Keiran Thompson and Florian Douetteau. Vol. 67: International Conference on Predictive
Applications and APIs Microsoft NERD, Boston, USA: pp. 1–13.
27
Hahn, P Richard, Jared Murray and Carlos M Carvalho. 2017. “Bayesian regression tree models
for causal inference: regularization, confounding, and heterogeneous effects.”.
Hahn, P. Richard, Vincent Dorie and Jared S. Murray. 2018. Atlantic Causal Inference Conference
(ACIC) Data Analysis Challenge 2017. Technical Report. School of Mathematical and Statistical
Sciences. https://math.la.asu.edu/~prhahn/debrief.pdf.
Hamburg, Margaret A. and Francis S. Collins. 2010. “The Path to Personalized Medicine.” New
England Journal of Medicine 363:301–304.
Hill, Jennifer L. 2011. “Bayesian nonparametric modeling for causal inference.” Journal of Com-
putational and Graphical Statistics 20:217–240.
Imai, Kosuke and Aaron Strauss. 2011. “Estimation of Heterogeneous Treatment Effects from
Randomized Experiments, with Application to the Optimal Planning of the Get-out-the-vote
Campaign.” Political Analysis 19:1–19.
Imai, Kosuke and Marc Ratkovic. 2013. “Estimating Treatment Effect Heterogeneity in Random-
ized Program Evaluation.” Annals of Applied Statistics 7:443–470.
Ku¨nzel, So¨ren R., Jasjeet S. Sekhon, Peter J. Bickel and Bin Yu. 2018. Meta-learners for Estimating
Heterogeneous Treatment Effects using Machine Learning. Technical Report. arXiv:1706.03461.
Laber, E. B. and Y. Q. Zhao. 2015. “Tree-based methods for individualized treatment regimes.”
Biometrika 102:501–514.
Mosteller, Frederick. 1995. “The Tennessee Study of Class Size in the Early School Grades.” The
Future of Children 5:113–127.
Nadeau, Claude and Yoshua Bengio. 2000. Inference for the generalization error. In Advances in
neural information processing systems. pp. 307–313.
Neyman, J. 1923. “On the application of probability theory to agricultural experiments: Essay
on principles, Section 9. (Translated in 1990).” Statistical Science 5:465–480.
Qian, Min and Susan A. Murphy. 2011. “Performance Gurantees for Individualized Treatment
Rules.” Annals of Statistics 39:1180–1210.
28
Rzepakowski, Piotr and Szymon Jaroszewicz. 2012. “Decision Trees for Uplift Modeling with
Single and Multiple Treatments.” Knowledge and Information Systems 32:303–327.
Stuard, A and J Keith Ord. 1994. Kendalls Advanced Theory of Statistics. Volume 1. Distribution
Theory. Halsted Press, New York, NY.
Tibshirani, Robert. 1996. “Regression shrinkage and selection via the lasso.” Journal of the Royal
Statistical Society: Series B (Methodological) 58:267–288.
Wager, Stefan and Susan Athey. 2018. “Estimation and Inference of Heterogeneous Treatment
Effects using Random Forests.” Journal of the American Statistical Association 113:1228–1242.
Zhang, Baqun, Anastasios A. Tsiatis, Eric B. Laber and Marie Davidian. 2012. “A Robust Method
for Estimating Optimal Treatment Regimes.” Biometrics 68:1010–1018.
Zhao, Yingqi, Donglin Zeng, John A. Rush and Michael R. Kosorok. 2012. “Estimating Individu-
alized Treatment Rules Using Outcome Weighted Learning.” Journal of the American Statistical
Association 107:1106–1118.
Zhou, Xin, Nicole Mayer-Hamblett, Umer Khan and Michael R. Kosorok. 2017. “Residual
Weighted Learning for Estimating Individualized Treatment Rules.” Journal of the American
Statistical Association 112:169–187.
29
A Mathematical Appendix
A.1 Proof of Theorem 1
To prove Theorem 1, we first consider the sample average prescription effect (SAPE),
τ sf =
1
n
n∑
i=1
{Yi(f(Xi))− pˆfYi(1)− (1− pˆf )Yi(0)} . (A1)
and its unbiased estimator,
τˆ sf =
1
n1
n∑
i=1
YiTif(Xi) +
1
n0
n∑
i=1
Yi(1− Ti)(1− f(Xi))− pˆf
n1
n∑
i=1
YiTi− 1− pˆf
n0
n∑
i=1
Yi(1− Ti) (A2)
This estimator differs from the estimator of the PAPE by a small factor, i.e., τˆ sf = (n − 1)/nτˆf .
The following lemma derives the bias and variance in the finite sample framework.
Lemma 1 (Bias and Variance of the Estimator for the SAPE) Under Assumptions 2, 1, and 3,
the bias and variance of the estimator of the PAPE given in equation (A2) for estimating the SAPE
defined in equation (A1) are given by,
E(τˆ sf | {Yi(1), Yi(0),Xi}ni=1) = τ sf
V(τˆ sf | {Yi(1), Yi(0),Xi}ni=1) =
1
n
(
n0
n1
S2f1 +
n1
n0
S2f0 + 2Sf01
)
where
Sf01 =
1
n− 1
n∑
i=1
(Y ∗i (0)− Y ∗(0))(Y ∗i (1)− Y ∗(1)).
Proof For the sake of notational simplicity, let On = {Yi(1), Yi(0),Xi}ni=1. Then, we take the
expectation with respect to the experimental treatment assignment, i.e., Ti,
E(τˆ sf | On) = E
(
1
n1
n∑
i=1
f(Xi)TiYi(1) +
1
n0
n∑
i=1
(1− f(Xi))(1− Ti)Yi(0)
− pˆf
n1
n∑
i=1
TiYi(1)− 1− pˆf
n0
n∑
i=1
(1− Ti)Yi(0)
∣∣∣∣∣ On
)
=
1
n
n∑
i=1
Yi(1)f(Xi) +
1
n
n∑
i=1
Yi(0)(1− f(Xi))− pˆf
n
n∑
i=1
Yi(1)− 1− pˆf
n
n∑
i=1
Yi(0)
= τ sf
To derive the variance, we first rewrite the proposed estimator as,
τˆ sf = τ
s
f +
n∑
i=1
Di(f(Xi)− pˆf )
(
Yi(1)
n1
+
Yi(0)
n0
)
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where Di = Ti−n1/n. Thus, noting E(Di) = 0, E(D2i ) = n0n1/n2, and E(DiDj) = −n0n1/{n2(n−
1)} for i 6= j, after some algebra, we have,
V(τˆ sf | On) = V(τˆ sf − τ sf | On)
= E
{ n∑
i=1
Di
(
Y ∗i (1)
n1
+
Y ∗i (0)
n0
)}2 ∣∣∣∣∣ On
 = 1
n
(
n0
n1
S2f1 +
n1
n0
S2f0 + 2Sf01
)
2
Now, we prove Theorem 1. Using Lemma 1 and the law of iterated expectation, we have,
E(τˆ sf ) = E
[
1
n
n∑
i=1
{Yi(f(Xi))− pˆfYi(1)− (1− pˆf )Yi(0)}
]
We compute the following expectation for t = 0, 1,
E
[
n∑
i=1
pˆfYi(t)
]
= E
[
n∑
i=1
∑n
j=1 f(Xj)
n
Yi(t)
]
=
1
n
E
[
n∑
i=1
f(Xi)Yi(t) +
n∑
i=1
∑
j 6=i
f(Xj)Yi(t)
]
= E{f(Xi)Yi(t)}+ (n− 1)pfE(Yi(t)).
Putting them together yields the following bias expression,
E(τˆ sf ) = E
[
{Yi(f(Xi))− 1
n
f(Xi){Yi(1)− Yi(0)} − n− 1
n
pf{Yi(1)− Yi(0)} − Yi(0)]
]
= τf − 1
n
E [{f(Xi)Yi(1)− (1− f(Xi))Yi(0)} − {pfYi(1)− (1− pf )Yi(0)}]
= τf − 1
n
Cov(f(Xi), Yi(1)− Yi(0))
We can further rewrite the bias as,
− 1
n
Cov(f(Xi), Yi(1)− Yi(0))
=
1
n
pf{E(Yi(1)− Yi(0) | f(Xi) = 1)− E(Yi(1)− Yi(0))}
=
1
n
pf (1− pf ){E(Yi(1)− Yi(0) | f(Xi) = 1)− E(Yi(1)− Yi(0) | f(Xi) = 0)}
=
1
n
τf . (A3)
This implies the estimator for the PAPE is unbiased, i.e., E(τˆf ) = τf .
To derive the variance, Lemma 1 implies,
V(τˆf ) =
n2
(n− 1)2
[
V
(
1
n
n∑
i=1
{Y ∗i (1)− Y ∗i (0)}
)
+ E
{
1
n
(
n0
n1
S2f1 +
n1
n0
S2f0 + 2Sf01
)}]
(A4)
31
Applying Lemma 1 of Nadeau and Bengio (2000) to the first term within the square brackets
yields,
V
(
1
n
n∑
i=1
{Y ∗i (1)− Y ∗i (0)}
)
= Cov(Y ∗i (1)−Y ∗i (0), Y ∗j (1)−Y ∗j (0))+
1
n
E(S2f1+S2f0−2Sf01) (A5)
where i 6= j. Focusing on the covariance term, we have,
Cov(Y ∗i (1)− Y ∗i (0), Y ∗j (1)− Y ∗j (0))
= Cov
({
f(Xi)− 1
n
n∑
i′=1
f(Xi′)
}
(Yi(1)− Yi(0)),
{
f(Xj)− 1
n
n∑
j′=1
f(Xj′)
}
(Yj(1)− Yj(0))
)
= −2Cov
(
n− 1
n
f(Xi)(Yi(1)− Yi(0)), 1
n
f(Xi)(Yj(1)− Yj(0))
)
+
∑
i′ 6=i,j
Cov
(
1
n
f(Xi′)(Yi(1)− Yi(0)), 1
n
f(Xi′)(Yj(1)− Yj(0))
)
+2
∑
i′ 6=i,j
Cov
(
1
n
f(Xj)(Yi(1)− Yi(0)), 1
n
f(Xi′)(Yj(1)− Yj(0))
)
+Cov
(
1
n
f(Xj)(Yi(1)− Yi(0)), 1
n
f(Xi)(Yj(1)− Yj(0))
)
= −2(n− 1)τ
n2
Cov (f(Xi), f(Xi)(Yi(1)− Yi(0))) + (n− 2)τ
2
n2
V(f(Xi))
+
2(n− 2)τ
n2
pfCov (f(Xi), Yi(1)− Yi(0))
+
1
n2
{
Cov2 (f(Xi), Yi(1)− Yi(0)) + 2pfτCov (f(Xi), Yi(1)− Yi(0))
}
=
1
n2
Cov2 (f(Xi), Yi(1)− Yi(0)) + (n− 2)τ
2
n2
pf (1− pf )
+
2(n− 1)τ
n2
Cov (f(Xi), (pf − f(Xi))(Yi(1)− Yi(0)))
=
1
n2
{
τ 2f + (n− 2)pf (1− pf )τ 2 + 2(n− 1)τ{+pfτf − (1− pf )E(Yi(f(Xi))− Yi(0))
}
=
1
n2
{
τ 2f + (n− 2)pf (1− pf )τ 2 + 2(n− 1)τ{+τf (2pf − 1)− (1− pf )pfτ
}
=
1
n2
{
τ 2f − npf (1− pf )τ 2 + 2(n− 1)(2pf − 1)τfτ
}
where the third equality follows from the formula for the covariance of products of two ran-
dom variables (Bohrnstedt and Goldberger, 1969). Finally, combining this result with equa-
tions (A4) and (A5) yields,
V(τˆf ) =
n2
(n− 1)2
[E(S2f1)
n1
+
E(S2f0)
n0
+
1
n2
{
τ 2f − npf (1− pf )τ 2 + 2(n− 1)(2pf − 1)τfτ
}]
2
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A.2 Proof of Theorem 2
We begin by deriving the variance expression. The derivation proceeds in the same fashion as the
one for Theorem 1. The only non-trivial change is the derivation of the covariance term, which
we detail below. First, we note that
Pr(f(Xi, cˆp) = 1) =
∫ ∞
−∞
Pr(f(Xi, c) = 1 | cˆp = c)P (cˆp = c)dc
=
∫ ∞
−∞
bnpc
n
P (cˆp = c)dc
=
bnpc
n
where the second equality follows from the fact that once conditioned on cˆp = c, exactly bnpc
out of n units will be assigned to the treatment condition. Given this result, we can compute the
covariance as follows,
Cov(Y˜i(1)− Y˜i(0), Y˜j(1)− Y˜j(0))
= Cov ((f(Xi, cˆp)− p) (Yi(1)− Yi(0)), (f(Xj, cˆp)− p) (Yj(1)− Yj(0)))
= Cov (f(Xi, cˆp)(Yi(1)− Yi(0)), f(Xj, cˆp)(Yj(1)− Yj(0)))
−2pCov ((Yi(1)− Yi(0)), f(Xj, cˆp)(Yj(1)− Yj(0)))
=
nbnpc(bnpc − 1)− bnpc2(n− 1)
n2(n− 1) E(Yi(1)− Yi(0) | f(Xi, cˆp) = 1)
2
−2pCov ((Yi(1)− Yi(0)), f(Xj, cˆp)(Yj(1)− Yj(0)))
=
bnpc(bnpc − n)
n2(n− 1) κ1(Xi, cˆp)
2 +
2pbnpc(n− bnpc)
n2(n− 1)
(
κ1(Xi, cˆp)
2 − κ1(Xi, cˆp)κ0(Xi, cˆp)
)
= (2p− 1)bnpc(n− bnpc)
n2(n− 1) κ1(Xi, cˆp)
2 − 2pbnpc(n− bnpc)
n2(n− 1) κ1(Xi, cˆp)κ0(Xi, cˆp)
=
bnpc(n− bnpc)
n2(n− 1)
{
(2p− 1)κ1(Xi, cˆp)2 − 2pκ1(Xi, cˆp)κ0(Xi, cˆp)
}
Combining this covariance result with the expression for the marginal variances yields the desired
variance expression for τˆf (cˆp).
Next, we derive the upper bound of bias. Using the same technique as the proof of Theorem 1,
we can rewrite the expectation of the proposed estimator as,
E(τˆf (cp)) = E
[
1
n
n∑
i=1
{Yi (f(Xi, cˆp))− pYi(1)− (1− p)Yi(0)}
]
Now, define F (c) = P(s(Xi) ≤ c). Without loss of generality, assume cˆp > cp (If this is not the
case, we simply switch the upper and lower limits of the integrals below). Then, the bias of the
estimator is given by,
|E(τˆf (cˆp))− τf (cp)| =
∣∣∣∣∣E
[
1
n
n∑
i=1
{Yi (f(Xi, cˆp))− Yi (f(Xi, cp))}
]∣∣∣∣∣
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=∣∣∣∣∣Ecˆp
[∫ cˆp
cp
E(Yi(1)− Yi(0) | s(Xi) = c)dF (c)
]∣∣∣∣∣
=
∣∣∣∣∣EF (cˆp)
[∫ F (cˆp)
F (cp)
E(Yi(1)− Yi(0) | s(Xi) = F−1(x))dx
]∣∣∣∣∣
≤ EF (cˆp)
[
|F (cˆp)− p| × max
c∈[cp,cˆp]
|E(Yi(1)− Yi(0) | s(Xi) = c)|
]
By the definition of cˆp, F (cˆp) is the bnpcth order statistic of n independent uniform random
variables, and thus follows the Beta distribution with the shape and scale parameters equal to
bnpc and n− bnpc+ 1), respectively. Therefore, we have,
P(|F (cˆp)− p| > ) = 1−B(p+ , bnpc, n− bnpc+ 1) +B(p− , bnpc, n− bnpc+ 1) (A6)
where B(, α, β) is the incomplete beta function, i.e.,
B(, α, β) =
∫ 
0
tα−1(1− t)β−1dt
Combining with the result above, the desired result follows. 2
A.3 Proof of Theorem 3
The derivation of the variance expression in Theorem 3 proceeds in the same fashion as Theorem 1
(see Appendix A.2) with the only non-trivial change being the calculation of the covariance term.
Note Pr(f(Xi, cˆk/n) = 1) = k/n for t = 0, 1 and nf = Z ∼ Binom(n, pf ). Then, we have:
Cov(Y †i (1)− Y †i (0), Y †j (1)− Y †j (0))
= Cov
{(∑nf
k=1 f(Xi, cˆk/n) +
∑n
k=nf+1
f(Xi, cˆnf/n)
n
− 1
2
)
(Yi(1)− Yi(0)),(∑nf
k=1 f(Xj, cˆk/n) +
∑n
k=nf+1
f(Xj, cˆnf/n)
n
− 1
2
)
(Yj(1)− Yj(0))
}
= E
[
Cov
{(∑Z
k=1 f(Xi, cˆk/n) +
∑n
k=Z+1 f(Xi, cˆZ/n)
n
− 1
2
)
(Yi(1)− Yi(0)),(∑Z
k=1 f(Xj, cˆk/n) +
∑n
k=Z+1 f(Xj, cˆZ/n)
n
− 1
2
)
(Yj(1)− Yj(0))
∣∣∣ Z}]
+Cov
[
E
{(∑Z
k=1 f(Xi, cˆk/n) +
∑n
k=Z+1 f(Xi, cˆZ/n)
n
− 1
2
)
(Yi(1)− Yi(0))
∣∣∣ Z} ,
E
{(∑Z
k=1 f(Xj, cˆk/n) +
∑n
k=Z+1 f(Xj, cˆZ/n)
n
− 1
2
)
(Yj(1)− Yj(0))
∣∣∣ Z}]
= E
[
− 1
n
{
Z∑
k=1
k(n− k)
n2(n− 1)κ1(Xi, cˆk/n)κ0(Xi, cˆk/n) +
Z(n− Z)2
n2(n− 1) κ1(Xi, cˆZ/n)κ0(Xi, cˆZ/n)
}
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− 2
n4(n− 1)
Z−1∑
k=1
Z∑
k′=k+1
k(n− k′)κ1(Xi, cˆk/n)κ1(Xi, cˆk′/n)
−Z
2(n− Z)2
n4(n− 1) κ1(Xi, cˆZ/n)
2 − 2(n− Z)
2
n4(n− 1)
Z∑
k=1
kκ1(Xi, cˆZ/n)κ1(Xi, cˆk/n)
+
1
n4
Z∑
k=1
k(n− k)κ1(Xi, cˆk/n)2
]
+ V
(
Z∑
i=1
i
n
κ1(Xi, cˆi/n) +
(n− Z)Z
n
κ1(Xi, cˆZ/n)
)
where the last equality is based on the results from Appendix A.2.
For the bias, we can rewrite Γf as,
Γf =
∫ pf
0
E{Yi(f(Xi, cp))}dp+ (1− pf )E{Yi(f(Xi, cpf ))}
and similarly its estimator Γ̂s as,
Γ̂f =
∫ pˆf
0
E{Yi(f(Xi, cp))}dp+ (1− pˆf )E{Yi(f(Xi, cˆpf ))}
Therefore, the bias of the estimator is:∣∣∣E(Γ̂f )− Γf ∣∣∣ ≤ E [|pf − pˆf | max
c∈{min{pˆf ,pf},max{pˆf ,pf}}
E{Yi(f(Xi, c))− Yi(f(Xi, cpf ))}|
+|E{Yi(f(Xi, cpf ))} − E{Yi(f(Xi, cˆpf ))}|
]
≤ (+ 1) max
c∈[cpf−,cpf+]
|E[Yi(f(Xi, c))− Yi(f(Xi, cpf ))]|
≤ (+ 1) max
c∈[cpf−,cpf+]
|E(Yi(1)− Yi(0) | s(Xi) = c)|
Now, taking the bound (1 + ) ≤ 2 for 0 ≤  ≤ 1 in equation (A6) of Appendix A.2, we have the
desired result. 2
A.4 Proof of Theorem 4
The proof of the bounds for the bias and variance of the proposed estimator largely follows the
proof given in Appendix A.2. The only significant difference is the calculation of the covariance
term, which is given below.
Cov(Y ∗i (1)− Y ∗i (0), Y ∗j (1)− Y ∗j (0))
= Cov
(
f(Xi, cˆ
f
p)− g(Xi, cˆgp))(Yi(1)− Yi(0)), (f(Xj, cˆfp)− g(Xj, cˆgp))(Yj(1)− Yj(0))
)
= Cov(f(Xi, cˆ
f
p)(Yi(1)− Yi(0)), f(Xj, cˆfp)(Yj(1)− Yj(0)))
+ Cov(g(Xi, cˆ
g
p)(Yi(1)− Yi(0)), g(Xj, cˆgp)(Yj(1)− Yj(0)))
−2 Cov(f(Xi, cˆfp)(Yi(1)− Yi(0)), g(Xj, cˆgp)(Yj(1)− Yj(0)))
=
bnpc(bnpc − n)
n2(n− 1)
(
κf1(Xi, cˆ
f
p)
2 + κg1(Xi, cˆ
g
p)
2
)
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−2 Cov(f(Xi, cˆfp)(Yi(1)− Yi(0)), g(Xj, cˆgp)(Yj(1)− Yj(0))).
Since the covariance term Cov(f(Xi, cˆ
f
p)(Yi(1)− Yi(0)), g(Xj, cˆgp)(Yj(1)− Yj(0))) is unidentifiable
without the covariance of the distribution of the scoring functions sf (X) and sg(X), we derive the
bounds by noting that the maximum covariance occurs when the scoring functions of f and g, i.e.,
sf (Xi) and sg(Xi), are perfectly correlated. This observation leads to the following result,
Cov(Y ∗i (1)− Y ∗i (0), Y ∗j (1)− Y ∗j (0))
≤ bnpc(bnpc − n)
n2(n− 1)
(
κf1(Xi, cˆ
f
p)
2 + κg1(Xi, cˆ
g
p)
2
)
+ 2
bnpcmax{bnpc, n− bnpc}
n2(n− 1) κ
f
1(Xi, cˆ
f
p)κ
g
1(Xi, cˆ
g
p)
which can then be used to obtain the results of Theorem 4. 2
A.5 Proof of Theorem 5
The proof proceeds in a manner similar to that of Appendix A.1. We first consider the following
estimator,
τˆ ∗sf =
1
nf
n∑
i=1
{
YiTˆi + Yi(1− f(Xi))
}
Fi − 1
nr
n∑
i=1
{YiTi + Yi(1− Ti)}(1− Fi) (A7)
This estimator differs from the ex-ante estimator of the PAPE τˆ sf , by a small factor, i.e., τˆ
∗s
f =
(n − 1)/nτˆ ∗f . The following lemma derives the bias and variance of this estimator. Using this
lemma, the results of Theorem 5 can be obtained immediately.
Lemma 2 (Bias and Variance of the Naive Estimator) Under Assumptions 2, 1, and 4,
the bias and variance of the estimator given in equation (A7) for estimating the PAPE defined in
equation (1) are given by,
E(τˆ ∗sf ) =
n− 1
n
τf
V(τˆ ∗sf ) =
E(S2f )
nf
+ E
{
pˆ2fS
2
1
nr1
+
(1− pˆf )2S20
nr0
}
+
1
n2
{
τ 2f − npf (1− pf )τ 2 + 2(n− 1)(2pf − 1)τfτ
}
Proof We first derive the bias expression. First, we take the expectation with respect to Ti,
E
[
1
nf
n∑
i=1
{Yif(Xi) + Yi(1− f(Xi))}Fi − 1
nr
n∑
i=1
(YiTi + Yi(1− Ti))(1− Fi)
∣∣∣ Xi, Yi(1), Yi(0), Fi]
=
1
nf
n∑
i=1
{Yif(Xi) + Yi(1− f(Xi))}Fi − 1
nr
n∑
i=1
{
Yi(1)
∑n
i=1 f(Xi)
nf
+ Yi(0)
(
1−
∑n
i=1 f(Xi)
nf
)}
(1− Fi)
Then we take the expectation with respect to Fi:
E
[
1
nf
n∑
i=1
{Yif(Xi) + Yi(1− f(Xi))}Fi
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− 1
nr
n∑
i=1
{
Yi(1)
∑n
i=1 f(Xi)
nf
+ Yi(0)
(
1−
∑n
i=1 f(Xi)
nf
)}
(1− Fi)
∣∣∣ Xi, Yi(1), Yi(0)]
=
1
n
n∑
i=1
Yi(f(Xi))− 1
nrnf
n∑
i=1
n∑
j=1
E
[
Yi(1)f(Xj)(1− Fi) + Yi(0)
(nf
n
− f(Xj)
)
(1− Fi) | Xi, Yi(1), Yi(0)
]
=
1
n
n∑
i=1
Yi(f(Xi))− 1
nrn
n∑
i=1
n∑
j=1
{nrn
n2
Yi(1)f(Xj) + Yi(0)
nfn
n2
(1− f(Xj))
}
=
1
n
n∑
i=1
Yi(f(Xi))− 1
n2
n∑
i=1
n∑
j=1
(Yi(1)f(Xj) + Yi(0) (1− f(Xj)))
Finally, we take the expectation over the sampling of {Xi, Yi(1), Yi(0)}:
E
[
1
n
n∑
i=1
Yi(f(Xi))− 1
n2
n∑
i=1
n∑
j=1
{Yi(1)f(Xj) + Yi(0) (1− f(Xj))}
]
= E{Yi(f(Xi))} − pfE(Yi(1))− (1− pf )E(Yi(0))− 1
n2
n∑
i=1
E{Cov(Yi(1), f(Xi)) + Cov(Yi(0), 1− f(Xi))}
= τf − Cov(Yi(1)− Yi(0), f(Xi))
=
n− 1
n
τf
where the last equality follows from the relation derived in Appendix A.1.
For the variance expression, we proceed as follows:
V(τ ∗sf ) = V{E(τ ∗sf | Xi, Yi(1), Yi(0), Fi)}+ E{V(τ ∗sf | Xi, Yi(1), Yi(0), Fi)}
= V
[
1
nf
n∑
i=1
{Yi(1)f(Xi) + Yi(0)(1− f(Xi))}Fi − 1
nr
n∑
i=1
{Yi(1)pˆf + Yi(0)(1− pˆf )}(1− Fi)
]
+ E
{
1
n2r
V
[
n∑
i=1
{YiTi + Yi(1− Ti)}(1− Fi)
∣∣∣ Xi, Yi(1), Yi(0), Fi]}
For the first term, we further use the law of total variance by conditioning on the sample, and
use the same proof strategy as the one used Appendix A.1 by centering Fi via the transformation
Di = Fi − nf/n. For the second term, we use the results of Neyman (1923), with the following
notation,
S2t =
1
n− 1
n∑
i=1
(Yi(t)− Y (t))2, S01 = 1
n− 1
n∑
i=1
(Yi(0)− Y (0))(Yi(1)− Y (1))
for t = 0, 1. Then, the variance becomes,
V(τ ∗sf ) = E
[
V
{
1
n
n∑
i=1
Di
(
n
nf
Y (f(Xi)) +
n
nr
Ŷi
) ∣∣∣ Xi, Yi(1), Yi(0)}]
+ V
{
1
n
n∑
i=1
(
Y (f(Xi))− Ŷi
)}
+ E
[
1
nr
{
pˆ2fnr0S
2
1
nr1
+
(1− pˆf )2nr1S20
nr0
− 2pˆf (1− pˆf )S01
}]
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where Ŷi = pˆfYi(1) + (1− pˆf )Yi(0).
Following the same analytical strategy as the one in Appendix A.1, we have,
V(τ ∗sf ) =
E(S2f )
nf
+
E(S2m)
nr
+ E
[
1
nr
{
pˆ2fnr0S
2
1
nr1
+
(1− pˆf )2nr1S20
nr0
− 2pˆf (1− pˆf )S01
}]
+ Cov((f(Xi)− pˆf )Yi(1)− (f(Xi)− pˆf )Yi(0), (f(Xi)− pˆf )Yi(1)− (f(Xi)− pˆf )Yi(0))
=
E(S2f )
nf
+
E(S2m)
nr
+ E
[
1
nr
{
pˆ2fnr0S
2
1
nr1
+
(1− pˆf )2nr1S20
nr0
− 2pˆf (1− pˆf )S01
}]
+
1
n2
{
τ 2f − npf (1− pf )τ 2 + 2(n− 1)(2pf − 1)τfτ
}
=
E(S2f )
nf
+ E
{
pˆ2fS
2
1
nr1
+
(1− pˆf )2S20
nr0
}
+
1
n2
{
τ 2f − npf (1− pf )τ 2 + 2(n− 1)(2pf − 1)τfτ
}
where S2m =
1
n−1
∑n
i=1(Ŷi − Ŷ )2 and the last equality follows from the E(S2m) = E{pˆ2fS21 + (1 −
pˆ2f )S
2
0 + 2pˆf (1− pˆf )S01}. 2
A.6 Details of the Comparison between Ex-ante and Ex-Post Evalua-
tions
A.6.1 Difference of the Variances
To compute the difference of the variance, we begin by defining the following,
Ai = pˆfYi(1)− pˆfY (1), Bi = (1− pˆf )Yi(0)− (1− pˆf )Y (0)
Ci = f(Xi)Yi(1)− f(X)Y (1), Di = (1− f(Xi))Yi(0)− (1− f(X))Y (0)
Then, a simple algebraic manipulation yields,
V(τˆf ) =
n2
(n− 1)2E
(
n∑
i=1
A2i + C
2
i − 2AiCi
n1(n− 1) +
B2i +D
2
i − 2BiDi
n0(n− 1) + ξ
)
V(τˆ ∗f ) =
n2
(n− 1)2E
(
n∑
i=1
A2i
nr0(n− 1) +
B2i
nr1(n− 1) +
C2i +D
2
i + 2CiDi
nf (n− 1) + ξ
)
where ξ = 1
n2
{
τ 2f − npf (1− pf )τ 2 + 2(n− 1)(2pf − 1)τfτ
}
.
Given these expressions, the difference is given by,
V(τˆ ∗f )− V(τˆf ) =
n2
(n− 1)2E
(
n∑
i=1
A2i (n1 − nr0)
nr0n1(n− 1) +
B2i (n0 − nr1)
nr1n0(n− 1) +
D2i (n0 − nf )
nfn0(n− 1)
+
2CiDi
nf (n− 1) +
2AiCi
n1(n− 1) +
2BiDi
n0(n− 1)
)
Under the assumption that n1 = n0 = nf = nr = n/2 and nr0 = nr1 = n/4, we have,
V(τˆ ∗f )− V(τˆf ) =
2n
(n− 1)2E
(
n∑
i=1
A2i +B
2
i
n− 1 +
2CiDi + 2AiCi + 2BiDi
n− 1
)
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=
2n
(n− 1)2
[
E
{
p2fS
2
1 + (1− pf )2S20
}
+ 2 Cov(f(Xi)Yi(1), (1− f(Xi))Yi(0))
+2pf Cov(f(Xi)Yi(1), Yi(1)) + 2(1− pf ) Cov((1− f(Xi))Yi(0), Yi(0)) ]
Finally, note the following,
Cov(f(Xi)Yi(1), (1− f(Xi))Yi(0))
= E{f(Xi)Yi(1) (f(Xi)− 1)Yi(0)} − E{f(Xi)Yi(1)}E{(1− f(Xi))Yi(0)}
= −Pr(f(Xi) = 1)E(Yi(1) | f(Xi) = 1) Pr(f(Xi) = 0)E(Yi(0) | f(Xi) = 0)
= −pf (1− pf )E(Yi(0) | f(Xi) = 0)E(Yi(1) | f(Xi) = 1)
and
pf Cov(f(Xi)Yi(1), Yi(1)) = p
2
f
{
E(Y 2i (1) | f(Xi) = 1)− E(Yi(1))E(Yi(1) | f(Xi) = 1)
}
(1− pf ) Cov(f(Xi)Yi(0), Yi(0)) = (1− pf )2
{
E(Y 2i (0) | f(Xi) = 0)− E(Yi(0))E(Yi(0) | f(Xi) = 0)
}
Hence, we have,
V(τˆ ∗f )− V(τˆf )
=
2n
(n− 1)2
[
p2fV(Yi(1)) + (1− pf )2V(Yi(0))− 2pf (1− pf )E(Yi(0) | f(Xi) = 0)E(Yi(1) | f(Xi) = 1)
+2p2f
{
E(Y 2i (1) | f(Xi) = 1)− E(Yi(1))E(Yi(1) | f(Xi) = 1)
}
+2(1− pf )2
{
E(Y 2i (0) | f(Xi) = 0)− E(Yi(0))E(Yi(0) | f(Xi) = 0)
}]
=
2n
(n− 1)2
[
p2fV(Yi(1)) + (1− pf )2V(Yi(0))− 2pf (1− pf )E(Yi(0) | f(Xi) = 0)E(Yi(1) | f(Xi) = 1)
+2p2f {V(Yi(1) | f(Xi) = 1)
+ (1− pf ){E(Yi(1) | f(Xi) = 1)− E(Yi(1) | f(Xi) = 0)}E(Yi(1) | f(Xi) = 1)}
+2(1− pf )2 {V(Yi(0) | f(Xi) = 0)
+ pf{E(Yi(0) | f(Xi) = 0)− E(Yi(0) | f(Xi) = 1)}E[Yi(0) | f(Xi) = 0]}
A.6.2 Comparison under the Simplifying Assumption
Define Mst = E(Yi(s) | f(Xi) = t) for s, t ∈ {0, 1}. Then, we can rewrite the variance difference
as,
V(τˆ ∗f )− V(τˆf ) =
2n
(n− 1)2
[
p2fV(Yi(1)) + (1− pf )2V(Yi(0))− 2pf (1− pf )M11M00
+2p2f {V(Yi(1) | f(Xi) = 1) + (1− pf )(M11 −M10)M11}
+ 2(1− pf )2 {V(Yi(0) | f(Xi) = 0) + pf (M00 −M01)M00}
]
Now consider a constant shift of the outcome variable, i.e., Yi(t)+δ for t = 0, 1. Then, the variance
difference becomes,
V(τˆ ∗f )− V(τˆf )
39
=
2n
(n− 1)2
[
p2fV(Yi(1)) + (1− pf )2V(Yi(0))− 2pf (1− pf )(M11 + δ)(M00 + δ)
+2p2f {V(Yi(1) | f(Xi) = 1) + (1− pf )(M11 −M10)(M11 + δ)}
+ 2(1− pf )2 {V(Yi(0) | f(Xi) = 0) + pf (M00 −M01)(M00 + δ)}
]
=
2n
(n− 1)2
[
p2fV(Yi(1)) + (1− pf )2V(Yi(0))− 2pf (1− pf )M11M00
+2p2f {V(Yi(1) | f(Xi) = 1) + (1− pf )(M11 −M10)M11}
+2(1− pf )2 {V(Yi(0) | f(Xi) = 0) + pf (M00 −M01)M00}
−2pf (1− pf )δ2 + 2pf (1− pf )δ {pf (M11 −M10) + (1− pf )(M00 −M01)−M11 −M00}]
=
2n
(n− 1)2
[
p2fV(Yi(1)) + (1− pf )2V(Yi(0))− 2pf (1− pf )M11M00
+2p2f {V(Yi(1) | f(Xi) = 1) + (1− pf )(M11 −M10)M11}
+2(1− pf )2 {V(Yi(0) | f(Xi) = 0) + pf (M00 −M01)M00}
−2pf (1− pf )δ2 − 2pf (1− pf )δ {pf (M00 +M10) + (1− pf )(M11 +M01)}]
Thus, we observe that the variance difference decreases by,
2pf (1− pf )δ2 + 2pf (1− pf )δ {pf (M00 +M10) + (1− pf )(M11 +M01)}
Note that since the ex-ante estimator is completely unaffected by this change, the constant shift
increases the variance of the ex-post evaluation estimator by the same amount. Under the simpli-
fying assumption, we have,
M11 +M01 = M00 +M10 = 0
Therefore, we can bound the variance difference from below as follows,
V(τˆ ∗f )− V(τˆf )
=
2n
(n− 1)2
[
p2fV(Yi(1)) + (1− pf )2V(Yi(0))− 2pf (1− pf )M11M00
+2p2f {V(Yi(1) | f(Xi) = 1) + (1− pf )(M11 −M10)M11}
+ 2(1− pf )2 {V(Yi(0) | f(Xi) = 0) + pf (M00 −M01)M00}
]
=
2n
(n− 1)2
[
p2fV(Yi(1)) + (1− pf )2V(Yi(0))− 2pf (1− pf )M11M00
+2p2f {V(Yi(1) | f(Xi) = 1) + (1− pf )(M11 +M00)M11}
+ 2(1− pf )2 {V(Yi(0) | f(Xi) = 0) + pf (M00 +M11)M00}
]
=
2n
(n− 1)2
[
p2fV(Yi(1)) + (1− pf )2V(Yi(0)) + 2p2fV(Yi(1) | f(Xi) = 1) + 2(1− pf )2V(Yi(0) | f(Xi) = 0)
+2pf (1− pf )
[
(1− pf )M200 + pfM211
]]
≥ 0
A.7 Additional Empirical Results
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AUPEC = 23.60 (s.e. = 4.02) AUPEC = 20.00 (s.e. = 4.14) AUPEC = -6.20 (s.e. = 4.13)
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AUPEC = 10.83 (s.e. = 3.92) AUPEC = 15.34 (s.e. = 4.08) AUPEC = 7.18 (s.e. = 4.04)
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AUPEC = 17.20 (s.e. = 4.17) AUPEC = 19.10 (s.e. = 4.23) AUPEC = 7.93 (s.e. = 4.16)
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Figure A1: Estimated Prescriptive Effect Curves for the Individualized Treatment Rules based
on BART, Causal Forest, and LASSO. Each row presents the results for a different outcome. For
each plot, the estimated Area Under Prescriptive Effect Curve (AUPEC) and its standard error
are shown. The solid lines represent the random assignment rule.
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